Interactive Transcript
0:00
So the first case was this, um,
0:02
enhancing mass involving the anterior skull base, and we can see that it's,
0:07
uh, homogeneously enhancing. The one, uh,
0:11
little thing I did want to point out was that there was a sickening here
0:15
involved in the anterior cranial fossa,
0:17
and this is a little bit of hyperos ptosis.
0:19
And in the old days we used to call this blistering of the bone on mr. Um,
0:24
and so this was a pretty straightforward case of, um,
0:29
a meningioma involving the anterior skull base and,
0:33
uh, just with some thickening the bone,
0:36
I think with the other term that we sometimes used as a plan and sphenoid alley
0:40
meningioma. Um, the one thing I did wanna point out,
0:44
a couple people mentioned this in the, in the report,
0:48
there is a lot of vasogenic edema surrounding this. And you know, the,
0:52
the one thing that I've seen over time is that if I see this vasogenic edema,
0:57
I always thought it was due to printable invasion.
1:00
But what I've noticed is that if the,
1:04
if it's an older patient and there's a lot of brain
1:09
atrophy, the, the,
1:14
the meningioma has space to grow so the,
1:18
the brain can kind of move around it. And so therefore in older patients,
1:23
we don't see a lot of edema. But this, I believe was a younger patient,
1:27
and so there's not a lot of, uh,
1:31
extra brain volume that's not occupied by brain tissue.
1:35
So when this tumor goes, it tends to compress the brain more.
1:39
So what I've noticed that in younger patients, if I see this vasogenic edema,
1:44
it doesn't necessarily mean that there's parenchymal invasion.
1:47
It doesn't necessarily mean that it's an invasive form in angioma.
1:51
It's just that this, um, brain parenchyma, um, it,
1:56
it's more prone to have base sugar edema because the brain is just non-compliant
2:00
around, there's just no place to move.
2:02
So I can stop there and take any questions you have on this one
2:07
And Dr.
2:08
Mochi for the hyper OSIS and M R I and we just look at the
2:13
configuration or is there any changes in the Cigna intensity?
2:19
Yeah, that's a good question. In general, um, the, the,
2:22
you'll see this bone right here that's expanding in just a little bit of
2:26
irregularity. Sometimes if the bone is really, really thickened,
2:29
you can sometimes see in this case there's some, let me,
2:33
let me get this non-contrast satchel T ones because it's probably better.
2:39
See in this case we can see the normal thickening of the bone should be
2:42
basically this caliber on the right. But you see how it's expanded.
2:45
Sometimes I've noticed it just be completely dark.
2:48
And then sometimes I have notes,
2:49
some intermediate signal within this and I'm not sure if it actually represents
2:52
fibrous tissue or maybe some early creation of marrow or fat within
2:57
it. I'm not a, not a hundred percent sure,
3:00
but the signal within this can be a little bit variable. But the main thing is,
3:04
is that, um, width of the bone is, is increased.
3:08
Any other questions on this one?
3:10
So for this kind of mening,
3:12
is there any relevance to the nerve like olfactory nerve we,
3:17
do we need to mention?
3:19
Yeah, it's a good question.
3:20
I think you can mention it if you can actually see the nerve. Um, you know,
3:25
there are lots of types of names for this meningioma I've,
3:28
I've seen it called anterior skull base meningioma.
3:31
I've seen it being called um, olfactory groove meningiomas.
3:36
If it's involved in the posterior aspect of sphenoid sinus,
3:39
I call planum sphenoid alley meningiomas. Um,
3:43
in general, if you want to, in, in this particular case,
3:47
you can actually see the tumor as extending inferiorly in valve in
3:52
the olfactory sulcus.
3:54
So if you want to say that the tumor's growing into the groove of the
3:58
olfactory nerve, I think that's completely fine.
4:02
Now is there any criteria,
4:03
like is it the size that based methods for the surgery?
4:08
Like for the, for the surgery to go in uhhuh? Yeah,
4:12
That's a really good question. Um, in fact,
4:15
I was just discussing that with one of our senior skull-based surgeons the other
4:18
day. Um, a lot of it depends on the symptoms. So I've seen, um,
4:24
for instance,
4:26
I've seen people follow meningiomas and I've seen people take 'em out and
4:31
I think a lot of it is depend on, like in this particular case,
4:34
they would take it out just based on the fact of the vasogenic edema.
4:37
The patient probably had headaches so they would take it out.
4:39
But sometimes in older patients,
4:41
if they see the meningiomas and the patients are essentially asymptomatic and
4:45
there's no vasogenic edema, then you can make an argument just to,
4:48
just to follow 'em.
4:51
Okay. They answers my question.
4:53
Does it,
4:54
I assume I have seen some of the patient they just follow up imaging wise. Yes.
4:59
But because this kind of patient have genic edema,
5:01
there is a chances to be a management type even though according to what
5:06
you say may be due to the young patient for the mass effect because of the
5:11
volume. Yes.
5:13
But sometimes it's very difficult to differentiate between the management
5:16
transformation just based on imaging.
5:21
Yes. Yeah. The only thing I would add to that,
5:23
I wouldn't necessarily use the term malignant transformation. Mm-hmm.
5:26
I would just say that some of the n genomes, um,
5:29
are more aggressive than others. So maybe they're aggressive.